Correction
for
Chen et al., Cancer Res 67 (10) 4924-4932.
Cancer Research 67, 5998, June 15, 2007. doi: 10.1158/0008-5472.CAN-67-12-COR3
© 2007 American Association for Cancer Research
Correction: Armed Anti-MUC16 Antibodies Are Efficacious
In the article describing the efficacy of anti-MUC16 antibody-drug conjugates in ovarian cancer models in the May 15, 2007 issue of Cancer Research (1), an author, Sarajane Ross, was inadvertently omitted from the author list. The correct author list should read as follows:
Youjun Chen, 1 Suzanna Clark, 2 Terence Wong, 3 Yongmei Chen, 3 Yvonne Chen, 3 Mark S. Dennis, 3 Elizabeth Luis, 4 Fiona Zhong, 5 Sheila Bheddah, 5 Hartmut Koeppen, 5 Alvin Gogineni, 6 Sarajane Ross, 2 Paul Polakis, 1 and William Mallet 1
Departments of 1Cancer Pathways and Targets, 2Translational Oncology, 3Antibody Engineering, 4Protein Chemistry, 5Pathology, and 6Biomedical Imaging, Genentech, Inc., South San Francisco, California
References
- Chen Y, Clark S, Wong T, Chen Y, Chen Y, Dennis MS, Luis E, Zhong F, Bheddah S, Koeppen H, Gogineni A, Polakis P, Mallet W. Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models. Cancer Res 2007;67:4924–32.[Abstract/Free Full Text]
